Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
1.280
+0.030 (2.40%)
At close: Nov 4, 2024, 4:00 PM
1.290
+0.010 (0.78%)
After-hours: Nov 4, 2024, 6:07 PM EST

Protalix BioTherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
94130693811849
Upgrade
Market Cap Growth
-36.49%87.08%83.20%-68.02%143.46%5.47%
Upgrade
Enterprise Value
73115822614189
Upgrade
Last Close Price
1.251.781.370.833.633.28
Upgrade
PE Ratio
-20.54-4.42-1.33-16.22-2.66
Upgrade
PS Ratio
2.401.981.460.991.880.89
Upgrade
PB Ratio
3.213.87-6.52-6.28-4.38-0.69
Upgrade
P/FCF Ratio
-20.51-52.64-2.71-3.23-4.43-2.44
Upgrade
P/OCF Ratio
-31.59-98.52-2.78-3.68-4.54-2.51
Upgrade
EV/Sales Ratio
1.921.751.720.682.241.62
Upgrade
EV/EBITDA Ratio
-4.719.86-6.85-1.3435.08-9.73
Upgrade
EV/EBIT Ratio
-4.3110.98-6.28-1.2751.93-8.26
Upgrade
EV/FCF Ratio
-15.22-46.57-3.19-2.21-5.26-4.43
Upgrade
Debt / Equity Ratio
0.920.78-3.15-5.55-2.38-0.87
Upgrade
Debt / EBITDA Ratio
-2.00--11.94-
Upgrade
Debt / FCF Ratio
-6.25-10.65-1.31-2.85-2.41-3.05
Upgrade
Asset Turnover
0.420.930.740.541.111.03
Upgrade
Inventory Turnover
1.281.281.131.051.021.30
Upgrade
Quick Ratio
0.951.110.841.290.480.58
Upgrade
Current Ratio
1.331.541.381.860.640.81
Upgrade
Return on Equity (ROE)
-43.48%72.50%----
Upgrade
Return on Assets (ROA)
-10.27%9.32%-12.57%-18.06%2.99%-12.58%
Upgrade
Return on Capital (ROIC)
-15.44%15.81%-32.36%-39.47%12.11%-
Upgrade
Earnings Yield
-15.98%6.40%-21.50%-72.80%-5.50%-37.55%
Upgrade
FCF Yield
-4.55%-1.90%-36.92%-31.00%-22.58%-41.06%
Upgrade
Buyback Yield / Dilution
-12.82%-70.04%-9.81%-51.43%-96.44%-0.85%
Upgrade
Total Shareholder Return
-12.82%-70.04%-9.81%-51.43%-96.44%-0.85%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.